Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 29,048 | 0 | 0 | 0 |
| Other current assets | 0 | 1,188 | 5,200 | 4,160 | 8,990 |
| TOTAL | $N/A | $30,236 | $5,200 | $4,160 | $8,990 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,242 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 51 | 18,710 | 14,550 | 4,370 |
| TOTAL | $N/A | $1,293 | $18,710 | $14,550 | $4,370 |
| Total Assets | $N/A | $31,391 | $23,910 | $18,710 | $13,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 140 | 0 |
| Accounts payable and accrued liabilities | 0 | 349 | 18,080 | 19,420 | 23,170 |
| Accrued Expenses | N/A | 1,191 | 6,290 | 8,210 | 11,660 |
| Other current liabilities | N/A | 0 | 3,780 | 6,660 | 1,620 |
| TOTAL | $N/A | $1,599 | $34,260 | $34,430 | $36,450 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 47,675 | 35,390 | 33,700 | 0 |
| TOTAL | $N/A | $47,709 | $35,390 | $33,700 | $0 |
| Total Liabilities | $N/A | $49,308 | $69,650 | $68,130 | $36,450 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 0 | 80 | 80 | 80 |
| Retained earnings | N/A | -18,585 | 0 | 0 | 0 |
| TOTAL | $N/A | $-17,917 | $79,000 | $79,000 | $79,000 |
| Total Liabilities And Equity | $0 | $31,391 | $148,650 | $147,130 | $115,450 |